Utah Medical Products Inc (UTMD) Return on Investment ROI from the second quarter of 2026 to second quarter of 2025 and for the year 2026, average high and low, overall ranking from Jun 30 2026 to Jun 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Utah Medical Products Inc  (NASDAQ: UTMD)


Utah Medical Products Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Utah Medical Products Inc's ROI in the second quarter of 2026?
Utah Medical Products Inc achieved a return on average invested assets (ROI) of 8.7 % in its second quarter of 2026, which is below Utah Medical Products Inc's average return on investment, which stands at 13.96%.

ROI fell compared to the first quarter of 2026, despite the net income growth of 3.15% from the first quarter of 2026.

Within the Healthcare sector 115 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 926 to 939.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Investment Change TTM 0.2 % -1.92 % -4.77 % -7.4 % -5.72 %
Y / Y Net Income Change TTM -16.47 % -16.29 % 13.78 % 65.65 % 263.57 %
Investment (TTM) in Millions 123 121 120 119 119
Return On Investment (TTM) 8.7 % 9.07 % 9.49 % 9.81 % 10.43 %
UTMD's Overall Ranking # 939 # 926 # 736 # 843 # 622
Seq. Investment Change TTM 0.83 % 0.56 % 0.34 % -1.52 % -1.3 %
Seq. Net Income Change TTM -3.34 % -3.87 % -2.9 % -7.42 % -3.13 %
Net Income (TTM) in Millions 10 11 11 12 13

UTMD Company Profile >> Back to UTMD Roi Comparisons >> See Annual UTMD Return On Investment



Return On Investment UTMD's Ranking
Within: No.
Industry # 38
Sector # 116
Overall # 939

Return On Investment Statistics
High Average Low
19.91 %
13.96 %
8.7 %
(Dec 31 2018)   (Jun 30 2026)







Financial Statements
Utah Medical Products Inc's II. Quarter Investments $ 123 Millions UTMD's Balance sheet
Utah Medical Products Inc's II. Quarter Income $ 3 Millions Quarterly UTMD's Income Statement
UTMD's Income by Division See UTMD's Income by Division


UTMD Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 120 118 131 118 112
Y / Y Investment Growth 1.38 % -9.51 % 10.88 % 5.38 % 3.65 %
Net Income in Millions 11 14 17 16 15
Y / Y Net Income Growth -18.65 % -16.6 % 0.98 % 11.39 % 36.95 %
Annual Return On Investment 9.41 % 11.73 % 12.72 % 13.97 % 13.22 %


Annual Roi Comment
In the fiscal year 2025 ROI decreased relative to the previous year to 9.41 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
UTMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for UTMD's Competitors
Subscribers only: Roi for Utah Medical Products Inc's Suppliers
Subscribers only: Return On Investment for UTMD's Customers

Other Ratios
UTMD's Roa UTMD's Inventory Turnover Ratio UTMD's Growth Rates UTMD's Dividend Statistics
UTMD's Profitability Ratios UTMD's Asset Turnover Ratio UTMD's Dividend Growth
UTMD's Roe UTMD's Valuation Ratios UTMD's Financial Strength Ratios UTMD's Dividend Payout Ratio



Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector ROI
Innoviva Inc   23.33 %
Electromed Inc   23.18 %
Zevra Therapeutics Inc   22.90 %
Iradimed Corporation  22.57 %
Alnylam Pharmaceuticals Inc   22.10 %
Eton Pharmaceuticals Inc   21.31 %
Dexcom Inc   20.98 %
Healthcare Services Group Inc   20.93 %
Arcutis Biotherapeutics Inc   20.77 %
Chemed Corporation  20.13 %
Resmed Inc   20.01 %
Halozyme Therapeutics Inc   19.99 %
Vertex Pharmaceuticals Inc  19.97 %
Agilent Technologies inc   19.84 %
Illumina Inc   19.61 %
Puma Biotechnology Inc   19.60 %
United Therapeutics Corporation  19.53 %
Zoetis Inc   19.44 %
Krystal Biotech Inc   19.16 %
Carlisle Companies Incorporated  18.88 %
Neurocrine Biosciences Inc   17.51 %
Intuitive Surgical Inc   17.11 %
Theravance Biopharma inc   17.10 %
Standard Biotools Inc   16.38 %
Inspire Medical Systems inc   16.34 %
Aveanna Healthcare Holdings Inc   16.32 %
Harmony Biosciences Holdings inc   15.85 %
Entera Bio Ltd   15.84 %
Nephros Inc   15.31 %
West Pharmaceutical Services Inc   15.29 %

Date modified: 2026-09-04T10:52:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.